Comorbidities in Type 2 Diabetes Mellitus

NCT05874141 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2025-08-14

No results posted yet for this study

Summary

Type 2 diabetes mellitus (DM) has adopted a top priority as it is a disease with an increasing prevalence. The number of people living with DM has increased more than fourfold over the past 40 years to more than 460 million people today

Conditions

Interventions

DIAGNOSTIC_TEST

HBA1C

blood sample on EDTA

DIAGNOSTIC_TEST

Lipid profile, including total, LDL, and HDL cholesterol and Triglycerides

serum sample

DIAGNOSTIC_TEST

Urine analysis and urinary albumin-to-creatinine ratio

Morning urine sample

DIAGNOSTIC_TEST

Serum creatinine and estimated glomerular filtration rate

serum sample

DIAGNOSTIC_TEST

Complete blood count

blood sample on EDTA

DIAGNOSTIC_TEST

Thyroid-stimulating hormone

serum sample

DIAGNOSTIC_TEST

Serum iron, TIBC, Transferrin saturation and serum ferritin if needed

serum sample

PROCEDURE

Electrocardiography (ECG)

by electrocardiogram

PROCEDURE

Transthoracic echocardiography, Neck ultrasonography if needed and abdominopelvic ultrasound

imaging

PROCEDURE

Arterial duplex ultrasound of both lower limbs

imaging

DIAGNOSTIC_TEST

Random blood glucose

serum sample

DIAGNOSTIC_TEST

AST, ALT, albumin

serum sample

Sponsors & Collaborators

  • New Valley University

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2025-12-30
Completion
2026-08-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05874141 on ClinicalTrials.gov